Literature DB >> 22290276

[Cutaneous adverse drug reactions in childhood and adolescence].

H Ott1.   

Abstract

Adverse drug reactions (ADR) occur in nearly 10% of hospitalized children and in about 1.5% of ambulatory pediatric patients. The skin is the most frequently affected target organ in drug hypersensitivity (DH) reactions, which account for 20% of all ADR. Due to its pathophysiological heterogeneity and the ensuing morphological diversity, DH often represents a clinical and therapeutic challenge. Urticarial and maculopapular eruptions are usually restricted to the skin and rarely require systemic treatment or hospital admission once the culprit drug has been withdrawn. However, extracutaneous affections should be ruled out promptly in individuals with polymorphous rashes accompanied by fever and lymphadenopathy as well as in patients with bullous skin lesions. Children affected by severe drug reactions usually require in-hospital surveillance and interdisciplinary supportive therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22290276     DOI: 10.1007/s00105-011-2197-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   1.198


  13 in total

Review 1.  NSAID hypersensitivity (respiratory, cutaneous, and generalized anaphylactic symptoms).

Authors:  Mario Sánchez-Borges
Journal:  Med Clin North Am       Date:  2010-05-13       Impact factor: 5.456

Review 2.  Drug hypersensitivity reactions: pathomechanism and clinical symptoms.

Authors:  Werner J Pichler; Jaqueline Adam; Barbara Daubner; Thomas Gentinetta; Monika Keller; Daniel Yerly
Journal:  Med Clin North Am       Date:  2010-07       Impact factor: 5.456

3.  Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.

Authors:  Jürgen Schneck; Jean-Paul Fagot; Peggy Sekula; Bruno Sassolas; Jean Claude Roujeau; Maja Mockenhaupt
Journal:  J Am Acad Dermatol       Date:  2007-10-04       Impact factor: 11.527

Review 4.  Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.

Authors:  P Impicciatore; I Choonara; A Clarkson; D Provasi; C Pandolfini; M Bonati
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

Review 5.  "Urticaria multiforme": a case series and review of acute annular urticarial hypersensitivity syndromes in children.

Authors:  Kara N Shah; Paul J Honig; Albert C Yan
Journal:  Pediatrics       Date:  2007-05       Impact factor: 7.124

Review 6.  Drug-induced urticaria.

Authors:  Eunice K H Tan; Clive E H Grattan
Journal:  Expert Opin Drug Saf       Date:  2004-09       Impact factor: 4.250

Review 7.  Toxic epidermal necrolysis (Lyell's disease).

Authors:  Mario Lissia; Pietro Mulas; Antonio Bulla; Corrado Rubino
Journal:  Burns       Date:  2009-09-18       Impact factor: 2.744

Review 8.  An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.

Authors:  Mark Jean-Aan Koh; Yong-Kwang Tay
Journal:  Curr Opin Pediatr       Date:  2009-08       Impact factor: 2.856

Review 9.  Cutaneous reactions to drugs in children.

Authors:  Alissa R Segal; Kevin M Doherty; John Leggott; Barrett Zlotoff
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

10.  Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.

Authors:  Natacha Levi; Sylvie Bastuji-Garin; Maja Mockenhaupt; Jean-Claude Roujeau; Antoine Flahault; Judith P Kelly; Elvira Martin; David W Kaufman; Patrick Maison
Journal:  Pediatrics       Date:  2009-01-19       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.